Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

09/07/2025
3 papers selected
3 analyzed

Three perioperative studies stand out today: ultra-early quantitative SSEP markedly improved neurological prognostication after cardiac arrest; a multicentre pediatric study found preoperative nocturnal hypoxaemia does not heighten fentanyl ventilatory sensitivity under anesthesia; and integrative transcriptomics with in vivo validation identified lactylation-related regulators driving lung ischemia-reperfusion injury after transplantation.

Summary

Three perioperative studies stand out today: ultra-early quantitative SSEP markedly improved neurological prognostication after cardiac arrest; a multicentre pediatric study found preoperative nocturnal hypoxaemia does not heighten fentanyl ventilatory sensitivity under anesthesia; and integrative transcriptomics with in vivo validation identified lactylation-related regulators driving lung ischemia-reperfusion injury after transplantation.

Research Themes

  • Ultra-early neuroprognostication using quantitative SSEP after cardiac arrest
  • Opioid ventilatory pharmacodynamics in pediatric OSA under anesthesia
  • Lactylation-driven mechanisms in lung ischemia-reperfusion injury after transplantation

Selected Articles

1. Ultra-early short- and middle-latency SSEP accurately predict good and poor outcome after cardiac arrest.

76Level IIICohort
Resuscitation · 2025PMID: 40914341

Within 6 hours post–cardiac arrest, quantitative short- and middle-latency SSEP parameters (N20 amplitude/duration and presence of N70) accurately predicted both poor and good neurological outcomes, outperforming other early predictors. Absent N20 remained perfectly specific for poor outcome, while high-amplitude N20 with preserved N70 predicted good outcome with high sensitivity and specificity.

Impact: Provides an actionable, ultra-early prognostic tool that can guide ICU decisions on sedation, prognostication, and communication with families. Combines quantitative SSEP features to boost sensitivity without sacrificing specificity.

Clinical Implications: Supports integrating ultra-early quantitative SSEP into multimodal neuroprognostication to inform early care pathways, targeted temperature management decisions, and resource allocation. Adoption should await multicentre validation and standardized protocols.

Key Findings

  • Bilateral absent N20 predicted poor outcome with 100% specificity and 67% sensitivity.
  • Combining low-amplitude (<1.2 µV), prolonged (>10 ms) N20 without N70 raised sensitivity to 93% while maintaining specificity.
  • High-amplitude (>3 µV) N20 with normal duration and preserved N70 predicted good outcome with 94% sensitivity and 100% specificity, outperforming other early predictors.

Methodological Strengths

  • Prospective, standardized, ultra-early multimodal assessment within 6 hours post-arrest
  • Quantitative SSEP metrics (amplitude, duration, N70) directly compared with EEG, clinical, CT, and NSE

Limitations

  • Single-centre design with modest sample size (n=65)
  • Needs external validation and protocol harmonization before widespread adoption

Future Directions: Multicentre validation with predefined quantitative thresholds, assessment under targeted temperature management, and integration into decision-support algorithms.

BACKGROUND: Accurate prognostication following cardiac arrest (CA) is crucial for informing clinical decisions. Current guidelines do not recommend a specific time point for recording somatosensory evoked potentials (SSEPs) after CA. We evaluated the ability of ultra-early short- and middle-latency SSEPs to predict good an poor neurological outcome and compared its accuracy with that of other predictors recorded early after CA. METHODS: Prospective single-centre study. Sixty-five comatose adults underwent a multimodal prognostic assessment, including neurophysiological (SSEPs and electroencephalogram [EEG]), clinical (pupillary reflexes and myoclonus), and imaging indices (brain computed tomography [CT]) within 6 h post-CA. Serum neuron-specific enolase (NSE) was sampled 12 h post-CA. We analysed the SSEPs N20 wave amplitude and duration, and the presence of the middle-latency N70 wave. Poor outcome was defined as a Cerebral Performance Category (CPC) of 3-5 at hospital discharge. RESULTS: A bilaterally absent N20 wave predicted poor outcome with 100[89-100]% specificity and 67[48-82]% sensitivity. Adding low-amplitude (<1.2 µV), prolonged (>10 ms) N20 waves without N70 increased sensitivity to 93[79-99]% without compromising specificity. Conversely, a high-amplitude (>3 µV) N20 wave with normal duration with preserved N70 predicted good outcome with 94[79-99]% sensitivity and 100[89-100]% specificity. SSEPs outperformed all other early prognostic indices for both good and poor outcome prediction. All poor outcome patients had at least two concordant unfavourable predictors. CONCLUSIONS: Ultra-early quantitative assessment of short- and middle-latency SSEPs provides highly accurate prediction of both good and poor neurological outcomes after CA. This approach may enhance early clinical decision-making and warrants validation in larger cohorts.

2. Association of preoperative nocturnal hypoxaemia nadir and fentanyl ventilatory sensitivity in children with obstructive sleep apnoea undergoing general anaesthesia: a multicentre clinical cohort study.

71.5Level IIICohort
British journal of anaesthesia · 2025PMID: 40914728

In a multicentre cohort with in-cohort dose randomization (n=90), the ventilatory effects of a single fentanyl dose during sevoflurane anesthesia in children with OSA were not associated with the preoperative nocturnal SpO2 nadir. Findings suggest fentanyl dosing should not be adjusted solely based on sleep study hypoxaemia metrics.

Impact: Challenges a common dosing heuristic that children with OSA and profound nocturnal desaturation are more opioid-sensitive intraoperatively. Registered, multicentre design increases generalizability.

Clinical Implications: Avoid empiric opioid under-dosing solely due to low nocturnal SpO2 nadir in pediatric OSA; instead titrate fentanyl to effect with vigilant respiratory monitoring and multimodal analgesia.

Key Findings

  • Preoperative nocturnal SpO2 nadir did not predict ventilatory sensitivity to a single fentanyl dose during sevoflurane anesthesia.
  • In-cohort dose randomization across 90 children (2–8 years) undergoing adenotonsillectomy strengthened internal validity.
  • Findings argue against using sleep oximetry hypoxaemia metrics to determine intraoperative fentanyl dosing in pediatric OSA.

Methodological Strengths

  • Multicentre design with in-cohort dose randomization and clinical trial registration (NCT05051189)
  • Objective ventilatory assessment under standardized anesthetic conditions (sevoflurane)

Limitations

  • Abstract details on SpO2 stratification and exact ventilatory endpoints are truncated
  • Sample size (n=90) limits precision; intraoperative findings may not generalize to postoperative opioid sensitivity

Future Directions: Larger RCTs comparing opioid titration strategies by OSA severity; inclusion of postoperative respiratory outcomes and pharmacogenomic modifiers.

BACKGROUND: Obstructive sleep apnoea (OSA) has been thought to increase the risk of respiratory depression from opioids. The primary aim of this study was to assess whether preoperative hypoxaemia by sleep study pulse oximetry imparts greater opioid sensitivity. METHODS: A multicentre observational cohort study with in-cohort dose randomisation was performed in children 2-8 yr of age with OSA undergoing adenotonsillectomy. Ninety patients were assigned to one of two Spo RESULTS: Ninety patients underwent in-cohort randomisation (Spo CONCLUSIONS: Single-dose fentanyl ventilatory effects in paediatric OSA patients during sevoflurane anaesthesia were not associated with preoperative nocturnal hypoxaemia nadir. Fentanyl dosing in children with OSA should not be determined by sleep study Spo CLINICAL TRIAL REGISTRATION: NCT05051189.

3. Integrative analysis of scRNA-seq and bulk RNA-seq to identify lactylation-related gene signatures in lung ischemia-reperfusion injury after lung transplantation.

70Level VCase-control
International immunopharmacology · 2025PMID: 40914702

By integrating bulk and single-cell transcriptomics with machine learning and murine validation, the study identified four lactylation-related regulators (SLC2A3, MYC, NLRP3, PIGA) that stratify lung IRI after transplantation and correlate with elevated lactate and protein lactylation. Findings suggest metabolic-epigenetic lactylation as a therapeutic axis to improve graft outcomes.

Impact: Introduces lactylation biology into perioperative lung transplantation IRI, bridging omics discovery with in vivo validation and offering actionable molecular targets.

Clinical Implications: Encourages exploration of metabolic and epigenetic modulators (e.g., targeting NLRP3 or glucose transport via SLC2A3) to mitigate IRI; may inform biomarker-driven risk stratification pending clinical validation.

Key Findings

  • Identified six lactylation-related genes and refined four biomarkers (SLC2A3, MYC, NLRP3, PIGA) with strong diagnostic performance.
  • Consensus clustering delineated two molecular IRI subtypes with distinct lactylation dynamics.
  • Murine lung IRI showed elevated lactate and global protein lactylation with concordant hub gene expression changes.

Methodological Strengths

  • Integration of bulk and single-cell RNA-seq with external validation
  • Orthogonal in vivo validation (lactate assays, western blot, immunohistochemistry/fluorescence, RT-qPCR)

Limitations

  • Preclinical validation in murine models; no prospective human clinical validation
  • Sample sizes of discovery and validation datasets not detailed in abstract

Future Directions: Prospective clinical studies to validate biomarkers, interventional trials targeting lactylation pathways, and cell-type specific mechanistic dissection in human tissues.

BACKGROUND: Protein lactylation has been implicated in stress-responsive cellular mechanisms, yet its role in lung transplantation-associated ischemia-reperfusion injury (IRI) remains undefined. METHODS: Transcriptomic profiles from GSE145989 were analyzed through differential expression analysis (limma) and weighted gene co-expression network analysis (WGCNA). Integrating the identified genes with lactylation-related signatures uncovered key lactylation-related genes (LRGs) as potential targets. Consensus clustering stratified post-reperfusion samples into molecular subtypes with distinct lactylation dynamics. Machine learning algorithms, including least absolute shrinkage and selection operator (LASSO) and random forest, were employed to refine diagnostic biomarkers, which were subsequently incorporated into a nomogram model. External validation was performed using GSE18995 dataset, while single-cell RNA sequencing (GSE220797) was used to map cellular distributions. Lactate levels, global protein lactylation levels, and candidate gene expression were experimentally validated in a murine lung IRI model through lactic acid assay kit, western blotting, immunohistochemistry, immunofluorescence and RT-qPCR. RESULTS: Six LRGs were identified through differential expression patterns, co-expression networks, and lactylation signatures. Consensus clustering revealed two distinct molecular subtypes with differential IRI progression patterns. Four machine learning-optimized biomarkers (SLC2A3, MYC, NLRP3, PIGA) demonstrated robust diagnostic performance. Their differential expression was confirmed in GSE18995. Single-cell data analysis revealed their predominant expression in various cell types. Murine experiments confirmed elevated lactate concentrations in bronchoalveolar lavage fluid and plasma, accompanied by enhanced global protein lactylation and consistent hub gene expression alterations. CONCLUSIONS: This integrative transcriptomic analysis identifies four lactylation-associated regulators of pulmonary IRI, proposing novel therapeutic targets for improving graft survival in lung transplantation.